What should you know about mesothelioma non small cell lung cancer?

Mesothelioma usually begins in a thin lining around an organ, commonly the pleura around the lungs. Non-small cell lung cancer begins in lung tissue and includes types such as adenocarcinoma. Symptoms can overlap, including cough, chest discomfort, breathlessness, tiredness, and unintentional weight loss, so symptoms alone cannot identify the cancer type.

Doctors may combine scans, bronchoscopy or another procedure, and a biopsy examined by a pathologist. The report may describe the cell type and biomarkers that help select treatment. A second pathology review can be discussed when the diagnosis or origin remains uncertain.

Ask for the pathology report and the scan findings, then confirm whether the cancer began in the lung or its surrounding lining. Treatment may involve surgery, radiation, medicines, or a combination, depending on location, spread, general health, and test results. Lung lobectomy removes one lung lobe in selected situations; stereotactic body radiotherapy delivers focused radiation in carefully planned sessions. Immunotherapy or targeted therapy may be options when the tumour and health assessment support them.

Discuss the purpose of each proposed treatment, expected effects, and alternatives with the treating team. You can read about [Lung Lobectomy](/treatments/surgical-oncology/lung-lobectomy/) and [Targeted Therapy](/treatments/systemic-therapy/targeted-therapy/).

Get urgent help for severe or rapidly worsening breathlessness, blue lips, fainting, new confusion, or coughing up significant blood. Tell the cancer team promptly about fever, chest pain that is new or intense, inability to drink, or a sudden decline in activity. These symptoms need assessment regardless of which cancer type is suspected.

Where did the cancer start? What does the biopsy show? Were biomarker tests completed? What is the purpose of each scan? Which treatment is intended to control the tumour, relieve symptoms, or both?